Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
KPG | Ann: Capital change notice - share rights plan | 01/10/24 | 0 | 43 | |||
|
|||||||
KPG | Ann: Capital change notice - share rights plan | 01/10/24 | 0 | 31 | |||
|
|||||||
KPG | Ann: SPH Notice - Milford Asset Management Limited | 25/09/24 | 0 | 58 | |||
|
|||||||
KPG | Ann: Ongoing disclosure notice - Peter Alexander | 20/09/24 | 0 | 58 | |||
|
|||||||
KPG | Ann: Ongoing disclosure notice - MJ Daly | 20/09/24 | 0 | 36 | |||
|
|||||||
KPG | Ann: Ongoing disclosure notice - various - DRP | 20/09/24 | 0 | 57 | |||
|
|||||||
KPG | Ann: Capital change notice (DRP) | 20/09/24 | 0 | 55 | |||
|
|||||||
KPG | Ann: Dividend reinvestment plan strike price set at $0.9283 | 12/09/24 | 0 | 65 | |||
|
See All Discussions